Cancer Detection (Hrc & AOB)Tests

Global disease burden and deaths due to cancer are on the rise. Early detection can help win the war against cancer. Tissue-resident, pluripotent, very small embryonic-like stem cells (VSELs), present in multiple tissues, transform into cancer stem cells (CSCs) due to various insults, initiate cancer and are also responsible for metastasis and recurrence.

 

HrC Test has been developed, based on a published study using 1000 clinical samples, to detect cancers by examining VSELs/CSCs in circulation, while AOB Test is an NGS-based test that provides information regarding mutations and gene-expression changes in VSELs/CSCs/progenitors to better monitor/manage cancer patients.

​

HrC Genomics Test offers the potential for early detection of cancer using a common set of VSEL/CSC specific bio-markers in peripheral blood. The HrC test can detect all cancers, including solid, haematological, and soft tissue sarcomas. It can detect cancer very early, before tumour formation.